Podcasts

Episode 192: What Your Gut Has to Do with Parkinson’s

Interest in the gut microbiome and its potential role in Parkinson’s disease (PD) continues to grow. Before exploring the latest research, it’s helpful to understand what the microbiome is, the role it plays in overall health, and why researchers are studying its connection to Parkinson’s.

In this episode, we speak with Dr. Lisa Deuel from the University of Vermont Medical Center about what researchers currently know, and don’t know, about the relationship between the gut and Parkinson’s. She explains the gut-brain connection and discusses common gastrointestinal issues experienced by people with Parkinson’s, such as constipation and gastroparesis (limited ability to empty the stomach). She wraps up by sharing practical strategies to support gut health.

Key Takeaways:

  • Research is still limited on whether changes in the gut microbiome may contribute to the risk of developing Parkinson’s disease.
  • Gastrointestinal issues, including constipation and gastroparesis, are common non-movement symptoms of Parkinson’s.
  • Practical Strategies for Supporting Gut Health:
    • Stay hydrated and drink water 
    • Eat a high fiber diet in moderation
    • Consider probiotics 
    • Stay active and moving

Released: July 14, 2026

Raise Awareness

Parkinson’s Genes Explained: 5 Facts about LRRK2

🧠 What will you learn in this article?

This article describes 5 facts about LRRK2, a gene related to Parkinson’s disease: 

  • LRRK2 variants are changes in a Parkinson’s-related gene called LRRK2. These variants can change how brain cells function. 
  • These changes can increase a person’s chance of getting Parkinson’s later in life. 
  • Certain ethnic and ancestral groups have a higher chance of having a LRRK2 variant. 
  • Researchers are closely studying LRRK2 to find new treatments for PD. 
DNA double helix

Genes are the instructions for making the proteins that give us individual characteristics. Just as genes influence traits like eye color or height, sometimes there are changes to a person’s genes — called genetic variants or mutations — that increase the risk of developing certain diseases.

In some people, Parkinson’s disease (PD) can be linked to genetic factors. The PD GENEration: Powered by the Parkinson’s Foundation genetics study found that about 1 in 8 participants has a genetic variant related to Parkinson’s. 

This blog outlines five facts about one of the genes examined in PD GENEration, LRRK2, and why studying it is important for the entire Parkinson’s community. 

The Genetics of LRRK2 

LRRK2 (pronounced “Lark Two”) stands for Leucine-rich repeat kinase 2 and was discovered in 2002. Since then, studies have shown that variations in this gene are related to developing Parkinson’s disease. 

Everyone inherits two copies of the LRRK2 gene — one from each parent. Changes in LRRK2 follow a dominant inheritance pattern, meaning a variant in just one copy of the gene can increase a person’s risk for Parkinson’s disease. 

However, these variants also have “reduced penetrance,” which means that the gene doesn’t act alone to cause Parkinson’s. Whether someone with a LRRK2 variant eventually develops Parkinson’s depends on a combination of genetics and other factors like age and environment. Some people carry a LRRK2 variant but never show symptoms of PD.

1. LRRK2 variants are a common genetic contributor to developing late-onset Parkinson’s. 

PD GENEration, the international research study providing genetic testing and counseling at no cost for people with PD, looks for changes in several Parkinson’s-related genes including LRRK2. To date, PD GENEration has found that:

  • 12% of participants have a variant in one or more of the genes tested.
  • About 2% of participants have a LRRK2 variant.

Most PD (with or without a variant) is considered late-onset, starting later in life and involving changes like slowed movement and shaking.

The way Parkinson’s appears in people with a LRRK2 variant does not look physically different than Parkinson’s in people without this change. Because of the similarities, researchers are investigating whether understanding LRRK2 could open doors to new treatments for all people with Parkinson’s. 

2. Certain ethnic groups are more likely to have LRRK2 variants. 

Different ancestral and ethnic groups can have different risks for genetic diseases. Findings from PD GENEration show that 10.5% of people who identify as Ashkenazi Jewish, 4.0% of people who identify as Berber, and 3.8% of people who identify as Basque carried a LRRK2 variant — compared to 1.2% of people who identified as having none of these ancestries.

People with a higher chance of having a LRRK2 variant can use genetic testing like PD GENEration to better understand their genetic makeup for themselves and their families. 

“For me, it was reassuring to learn that I am a LRRK2 carrier, because then I knew that we had a target. There are clinical studies I can participate in to help advance the field. Within a week of learning that I have a genetic variant, I was participating in research, and I’ve been participating in research ever since.”

-Jessi Keavney, Parkinson’s Foundation Research Advocate

3. A variant in the LRRK2 gene may make it harder for cells to clear out unwanted material. 

The LRRK2 gene gives cells instructions to make the LRRK2 protein, which is responsible for powering the cell and directing nutrients and waste. A variant in LRRK2 can make the protein too active, disrupting the way a cell’s materials are normally transported. 

Research suggests that while LRRK2 normally helps cells clean up and recycle waste, LRRK2 variants may stop this system from working properly. Waste can collect in cells — including in brain cells called neurons. When this happens, the buildup can lead to inflammation and cell death. Early Parkinson’s symptoms appear after the loss of neurons that make dopamine, a chemical that helps the body coordinate movement.

4. LRRK2 is a target for new PD treatments. 

Scientists are highly focused on how mutations in the LRRK2 gene influence Parkinson’s disease. By developing treatments to calm or quiet an overactive LRRK2 gene, researchers hope to protect brain cells and potentially slow or halt the progression of Parkinson’s. 

There are several active clinical trials — studies that test new treatments — for therapies targeting LRRK2 in Parkinson’s. Some studies require a confirmed LRRK2 variant, which can be verified with clinical-grade genetic testing like PD GENEration.   

For those who have already participated in PD GENEration, our PD Trial Navigator program currently partners with Neuron23 for the Neulark trial for LRRK2. For more information about Neulark or other partner trials as they become available, email PDNavigator@parkinson.org

5. LRRK2 breakthroughs could benefit the entire PD community. 

Even highly targeted genetic research has the potential to help broader communities. For example, research into a rare genetic condition called familial hypercholesterolemia (FH) helped scientists discover how the body regulates cholesterol. This led to the creation of statins, a medication that lowers cholesterol and is widely used today by people with and without FH.

Enroll in Our Genetics Study

Understanding the connection between Parkinson's and genetics can help us figure out how the disease develops and ultimately the best way it can be treated or cured.

EXPLORE PARKINSON'S-RELATED GENES 
ENROLL NOW

Scientists are hoping LRRK2 research may hold broader promise because of the similarities between LRRK2-related Parkinson’s and the more common idiopathic Parkinson’s — PD without a known cause. What they discover could help many people with Parkinson's in the future. 

Learn More  

The Parkinson’s Foundation works to improve care for people with PD and advance research toward a cure. Learn more with these resources: 

Science News

Two New Studies Show Adaptive Deep Brain Stimulation May Improve Walking in Parkinson’s

🧠 What will you learn in this article?

This article highlights two studies, published in Nature Medicine, that show promise for using new adaptive deep brain stimulation (DBS) methods to treat walking difficulties in Parkinson’s disease (PD). Highlights include:

  • Unlike traditional DBS, adaptive DBS adjusts stimulation in real time based on movement or brain signals. 
  • Both studies identified personalized brain signals (neural biomarkers) to tailor stimulation for specific movement. Both approaches improved walking while preserving traditional DBS benefits for symptoms such as tremors and stiffness.
  • Researchers at Lausanne University Hospital in Switzerland used brain signals to identify and tailor stimulation for different activities. 
  • Researchers the University of California, San Francisco (UCSF) used different brain signals to time and adjust stimulation to participant’s walking rhythm.
Parkinson's Foundation Science News blogs

Deep brain stimulation (DBS) is the most common surgical treatment for Parkinson’s disease (PD). It uses continuous electrical pulses to help control movement symptoms like tremor, stiffness and slowness. For many, DBS can be life changing. Its big shortfall is that it delivers the same stimulation all the time, which does not help with walking difficulties — including unsteady gait, freezing of gait (a sudden inability to move when walking) and falls. These are among the most disabling and dangerous PD symptoms with limited treatment options.

Recently, major advancements have been made in adaptive DBS (aDBS), which is when a DBS device adjusts its stimulation in real time based on a person’s symptoms or behavior. Studies show that aDBS is more helpful for controlling typical “on/off” symptoms (such as tremor and rigidity) compared to traditional DBS treatment. Now, two new studies published in Nature Medicine suggest that aDBS may also hold promise for treating gait impairment in people with Parkinson’s. 

  1. One study, conducted by a team at Lausanne University Hospital in Switzerland, developed a system that uses brain signals to detect which locomotor (the ability to move) activity a person is performing — such as sitting, standing, walking or turning — and selects stimulation settings optimized for that specific activity.
  2. The other study, led by a team at the University of California, San Francisco (UCSF), took a different approach: timing stimulation to specific phases of the walking cycle, footstep by footstep, guided by brain signals unique to each individual participant.

Both studies were small and early-stage but highlight that adaptive DBS could improve walking in ways that traditional DBS cannot. 

Study Results

The primary focus of both studies was whether adaptive DBS settings that target gait are feasible and safe, and whether they could improve walking compared to traditional continuous stimulation. Encouragingly, neither study reported negative events. 

Adaptive DBS was well tolerated in all participants, and both studies found that it still helped manage the movement symptoms — like tremors and stiffness — that traditional DBS provides. Beyond safety, both teams also tracked changes in participants’ walking patterns, including step consistency, symmetry and falls.

2 new adaptive DBS studies graphic

The Swiss study enrolled six people with Parkinson’s who had DBS implants in the subthalamic nucleus. The team used recordings from the implanted DBS device, combined with detailed motion tracking, to develop algorithms that could detect which activity a person was performing — walking on flat ground, avoiding obstacles, turning, etc. — and automatically adjust stimulation settings to match.

  • This approach improved movement across multiple daily activities while preserving the benefits of traditional DBS for other movement symptoms.
  • This system successfully decoded and adjusted to locomotor activities in real time, even as participants’ symptoms changed or took levodopa medication throughout the day — a key challenge for adaptive approaches.

The UCSF study enrolled five people with Parkinson’s who received DBS implants in the globus pallidus region, along with additional recording devices in other brain regions. Using those recordings, they found that the brain produces distinct electrical patterns during specific phases of walking — for example, when the leg swings forward. 

These patterns were unique to each participant, appearing at different frequencies and brain locations. By identifying each person’s individual ‘gait signature,’ the researchers were able to program the neurostimulator to deliver brief boosts of stimulation timed to match each step.

  • During in-clinic testing, this adaptive DBS strategy improved step variability and step symmetry compared to traditional DBS stimulation.
  • Three participants completed a multi-day trial in their own homes, where neither the participants nor the researchers knew which type of stimulation was being used. In this real-world setting, adaptive DBS maintained general movement symptom control and reduced falls.

The UCSF study in this article was supported by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health. The Parkinson’s Foundation advocates for increased federal funding to advance PD research, improve treatments and move us closer to a cure.

While these are early results need to be confirmed in larger studies, they offer a promising glimpse into a fundamentally new way to address one of the most challenging aspects of Parkinson’s: walking difficulties.

Highlights

  • Two studies, both published in Nature Medicine, tested adaptive DBS systems designed to target movement symptoms that automatically adjust to what a person is doing in real time.
  • Both studies used personalized brain signals, unique to each participant, that specifically indicated different types of movement or activity. 
  • The Swiss study used activity states— for example, recognizing whether a person was sitting, walking, or turning — to switch between optimized stimulation settings.
  • The UCSF study used step-level precision — synchronizing stimulation pulses to the exact rhythm of each individual step – to make adjustments.
  • Both approaches improved walking measures while maintaining the benefits of traditional DBS for other movement symptoms like tremor and stiffness.
  • Neither study reported negative events and showed that these aDBS techniques were well tolerated.
  • Both studies were small (six and five participants). Larger trials are needed to confirm these findings.

What Does This Mean?

Falls are a leading cause of injury and hospitalization for people with Parkinson’s. Since walking is a highly complex activity that requires precise coordination, traditional DBS with consistent stimulation often does not address balance and walking issues. Instead of delivering the same stimulation all the time, adaptive DBS devices adjust in real-time based on the brain’s activity. These studies leveraged this concept to specifically target gait impairment, indicating an important shift in how DBS could help walking symptoms. 

If larger studies confirm these findings, adaptive DBS could offer a meaningful improvement in daily life for people living with Parkinson’s — especially those experiencing gait and balance challenges.

These studies worked by identifying unique, personalized brain signals that were specific to each participant. The algorithms for adaptive DBS were then optimized based on this brain activity — a form of individualized, precision medicine. In addition, the physical location of the participants’ DBS implant varied between studies; the success of both platforms indicates that these treatments can be effective regardless of the DBS implant location, offering hope for more people with Parkinson’s.  

What Does This Mean for People with Parkinson’s?

These studies are in the early stages and have only been tested on a very small number of people. Neither paradigm is ready for widespread clinical use. However, hope lies in the fact that these studies have already moved beyond the lab and are being tested in people living with Parkinson’s. Additionally, the Swiss study used a commercially available DBS neurostimulation device, removing an important barrier to access and suggesting that widespread implementation in the near future may be feasible. 

Next, larger trials will need to confirm the findings to improve features for long-term use and to better understand who would benefit most. People experiencing walking difficulties and falls related to Parkinson’s should talk to their doctor about current treatments and keep an eye out for future adaptive DBS clinical trials. 

Learn More

The Parkinson’s Foundation Helpline (1-800-4PD-INFO) provides answers to questions about PD symptoms and management. Learn more about this topic with the below resources: 

Educational Events

Speech & Swallowing

11:00 am to 2:30 pm EST
FREE
Speech and Swallowing Banner Updated

Check-in & Resource Fair* begins at 11:00 a.m. and the program starts at 11:30 a.m. 

Speech and swallowing challenges are common in Parkinson’s, but they can be managed. Participants will learn about voice changes and swallowing difficulties, along with strategies to improve communication and address swallowing challenges. We’ll also discuss the effect of speech and swallowing therapy on quality of life.

*The Resource Fair will feature local Community Partners that provide services and support for the Parkinson’s Community.

Speakers

Suja Sadasivan, MD
Assistant Professor of Neurology
Boston University School of Medicine

Anne Quirk, MA, MS, CCC-SLP
True Self Speech Therapy

Sandra Aguiar, MS, CCC-SLP
Brown University Health

Movement demonstration by 
Angelina DiNardo, MS, CCC-SLP
Speech-Language Pathologist
Rhode Island Hospital Outpatient Rehabilitation

The large parking lot in front of the JCC will be available.

There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their families, friends, and the community.

Upcoming Events

Educational Events

The PD Solo Network

Virtual ( Zoom )
1:00 pm to 9:00 pm EST
FREE
PD Solo event banner of woman staring out the window

Parkinson's Foundation: The PD Solo Network - Living Alone While Living with PD

There are two sessions available: You are welcome to choose one or attend both.
– 1 p.m. to 2:30 p.m. ET
– 7:30 p.m. to 9 p.m. ET


Please note: These meetings are intended for individuals diagnosed with Parkinson’s disease who live alone, by choice or circumstance – only. If this is not your situation, please contact the Parkinson’s Foundation Helpline to receive information about resources that best meet your needs. Call the Helpline at 1-800-473-4636 (1-800-4PD-INFO) or Helpline@Parkinson.org.


What is the PD Solo Network: 

A virtual network for people living with Parkinson's disease (PD) who live alone, by choice or circumstance. The purpose of this group is to create a community of support for those living without a care partner. People living with PD are the experts about what challenges, changes and accommodations are needed on a daily basis. This network will provide a place to share ideas, concerns, brainstorm strategies, suggestions, resources & to build relationships.

The Parkinson's Foundation is providing the initial funding and support to kick start this network. It will most likely become a very strong network that will operate independently although the Parkinson's Foundation will always be an entity of support & information for the participants.

2026 Meeting Date:

  • December 8, 2026

There is no charge to attend, but registration is required in order to receive the Zoom link.

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Educational Events

The PD Solo Network

Virtual ( Zoom )
1:00 pm to 9:00 pm EST
FREE
PD Solo event banner of woman staring out the window

Parkinson's Foundation: The PD Solo Network - Living Alone While Living with PD

There are two sessions available: You are welcome to choose one or attend both.
– 1 p.m. to 2:30 p.m. ET
– 7:30 p.m. to 9 p.m. ET


Please note: These meetings are intended for individuals diagnosed with Parkinson’s disease who live alone, by choice or circumstance – only. If this is not your situation, please contact the Parkinson’s Foundation Helpline to receive information about resources that best meet your needs. Call the Helpline at 1-800-473-4636 (1-800-4PD-INFO) or Helpline@Parkinson.org.


What is the PD Solo Network: 

A virtual network for people living with Parkinson's disease (PD) who live alone, by choice or circumstance. The purpose of this group is to create a community of support for those living without a care partner. People living with PD are the experts about what challenges, changes and accommodations are needed on a daily basis. This network will provide a place to share ideas, concerns, brainstorm strategies, suggestions, resources & to build relationships.

The Parkinson's Foundation is providing the initial funding and support to kick start this network. It will most likely become a very strong network that will operate independently although the Parkinson's Foundation will always be an entity of support & information for the participants.

2026 Meeting Dates:

  • November 10, 2026
  • December 8, 2026

There is no charge to attend, but registration is required in order to receive the Zoom link.

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Educational Events

The PD Solo Network

Virtual ( Zoom )
1:00 pm to 9:00 pm EST
FREE
PD Solo event banner of woman staring out the window

Parkinson's Foundation: The PD Solo Network - Living Alone While Living with PD

There are two sessions available: You are welcome to choose one or attend both.
– 1 p.m. to 2:30 p.m. ET
– 7:30 p.m. to 9 p.m. ET


Please note: These meetings are intended for individuals diagnosed with Parkinson’s disease who live alone, by choice or circumstance – only. If this is not your situation, please contact the Parkinson’s Foundation Helpline to receive information about resources that best meet your needs. Call the Helpline at 1-800-473-4636 (1-800-4PD-INFO) or Helpline@Parkinson.org.


What is the PD Solo Network: 

A virtual network for people living with Parkinson's disease (PD) who live alone, by choice or circumstance. The purpose of this group is to create a community of support for those living without a care partner. People living with PD are the experts about what challenges, changes and accommodations are needed on a daily basis. This network will provide a place to share ideas, concerns, brainstorm strategies, suggestions, resources & to build relationships.

The Parkinson's Foundation is providing the initial funding and support to kick start this network. It will most likely become a very strong network that will operate independently although the Parkinson's Foundation will always be an entity of support & information for the participants.

2026 Meeting Dates:

  • October 13, 2026
  • November 10, 2026
  • December 8, 2026

There is no charge to attend, but registration is required in order to receive the Zoom link.

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Educational Events

The PD Solo Network

Virtual ( Zoom )
1:00 pm to 9:00 pm EST
FREE
PD Solo event banner of woman staring out the window

Parkinson's Foundation: The PD Solo Network - Living Alone While Living with PD

There are two sessions available: You are welcome to choose one or attend both.
– 1 p.m. to 2:30 p.m. ET
– 7:30 p.m. to 9 p.m. ET


Please note: These meetings are intended for individuals diagnosed with Parkinson’s disease who live alone, by choice or circumstance – only. If this is not your situation, please contact the Parkinson’s Foundation Helpline to receive information about resources that best meet your needs. Call the Helpline at 1-800-473-4636 (1-800-4PD-INFO) or Helpline@Parkinson.org.


What is the PD Solo Network: 

A virtual network for people living with Parkinson's disease (PD) who live alone, by choice or circumstance. The purpose of this group is to create a community of support for those living without a care partner. People living with PD are the experts about what challenges, changes and accommodations are needed on a daily basis. This network will provide a place to share ideas, concerns, brainstorm strategies, suggestions, resources & to build relationships.

The Parkinson's Foundation is providing the initial funding and support to kick start this network. It will most likely become a very strong network that will operate independently although the Parkinson's Foundation will always be an entity of support & information for the participants.

2026 Meeting Dates:

  • September 15, 2026
  • October 13, 2026
  • November 10, 2026
  • December 8, 2026

There is no charge to attend, but registration is required in order to receive the Zoom link.

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Educational Events

The PD Solo Network

Virtual ( Zoom )
1:00 pm to 9:00 pm EST
FREE
PD Solo event banner of woman staring out the window

Parkinson's Foundation: The PD Solo Network - Living Alone While Living with PD

There are two sessions available: You are welcome to choose one or attend both.
– 1 p.m. to 2:30 p.m. ET
– 7:30 p.m. to 9 p.m. ET


Please note: These meetings are intended for individuals diagnosed with Parkinson’s disease who live alone, by choice or circumstance – only. If this is not your situation, please contact the Parkinson’s Foundation Helpline to receive information about resources that best meet your needs. Call the Helpline at 1-800-473-4636 (1-800-4PD-INFO) or Helpline@Parkinson.org.


What is the PD Solo Network: 

A virtual network for people living with Parkinson's disease (PD) who live alone, by choice or circumstance. The purpose of this group is to create a community of support for those living without a care partner. People living with PD are the experts about what challenges, changes and accommodations are needed on a daily basis. This network will provide a place to share ideas, concerns, brainstorm strategies, suggestions, resources & to build relationships.

The Parkinson's Foundation is providing the initial funding and support to kick start this network. It will most likely become a very strong network that will operate independently although the Parkinson's Foundation will always be an entity of support & information for the participants.

2026 Meeting Dates:

  • August 11, 2026
  • September 15, 2026
  • October 13, 2026
  • November 10, 2026
  • December 8, 2026

There is no charge to attend, but registration is required in order to receive the Zoom link.

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Educational Events

Mindfulness Mondays - Letting Go & Moving Forward

Virtual ( Zoom )
1:00 pm to 1:30 pm EST
Free
Woman sitting on the couch drinking coffee

As poet Maya Angelou once said, forgiveness is one of the greatest gifts we can give ourselves.” Forgiveness can release tension and open the heart to healing—especially when facing the changes Parkinson’s brings. This session offers a gentle, step-by-step mindfulness practice for forgiveness, helping to soften self-blame and resentment, and make room for acceptance and peace.

Speaker

Devon Hase
Author & Meditation Teacher

There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their family, friends, and the community.

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Back to Top